TITLE:
      Multicenter Clinical Trial of Buprenorphine - 3
SUMMARY:
      The purpose of this study is to test the efficacy and safety of buprenorphine.
DETAILED DESCRIPTION:
      12 different sites for a total of 736 subjects (60 at Pizarro, 70 at West LA Tx center, 15
      in the 1 year extension)
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F, ages 21-50. opiate dependence according to DSM-IV criteria. Self-reported use within
        the last 30 days. Agreeable to conditions of the study and signed informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hynotics.
        Acute hepatitis. Other medical conditions that deem participation to be unsafe.
